Economic evaluation in health: A thumb nail sketch

British Medical Journal

Volumn 316, Issue 7145, 1998, Pages 1663-1665

  Kernick, D P ^a  

^a The St Thomas Medical Group   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST UTILITY ANALYSIS; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH ECONOMICS; METHODOLOGY; PHARMACOECONOMICS; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT SURVEY;

EID: 0032580763     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.316.7145.1663     Document Type: Short Survey

References (11)

1. Drummond M. Economic analysis alongside control trials. London: Department of Health, 1994.
2. Sacristan J, Bolanos E, Hernandz J, Soto J, Galendel I. Publication bias in health economic studies. Pharmacoeconomics, 1997;11:289-90.
3. Robinson R, Cost benefit analysis. BMJ 1993;307:924-6.
4. Robinson R. Cost effectiveness analysis. BMJ 1993;307:793-5.
5. Robinson R. Cost utility analysis. BMJ 1993;307:859-62.
6. Rittenhouse B. The use of models in economic of medicines and other health technologies. London: Office of Health Economic, 1996.
7. Neuberger II, Parsonage M. Discounting and health benefits. Health Economics 1992;1:71-5.
8. Briggs A, Sculpher M, Buxton M. Uncertainty in the evalution of healthcare technologies: the role of the sensitivity analysis. Health Economics 1991;3:95-104.
9. Torgeston D, Spenser A. Marginal costs and benefits. BMJ 1996;312:35-6.
10. Ryan M, Shackley P. Assessing the benefits of health care: how far should we go? Quality in Health Care 1995;4:207-13.
11. Drummond MF, Jefferson TD. Guidelines for authors and peer reviewers of economic submission to the BMJ. BMJ 1996;313:275-83.